Metals accumulation affects bone and muscle in osteoporotic patients: A pilot study

osteoporosis is the most common bone disease, characterized by decreased bone mineral density (BMD) and often associated to decreased muscle mass and function. metal exposure plays a role in the pathophysiology of osteoporosis and affects also muscle quality. the aim of this study was to assess the association between metal levels in bone and muscle samples and the degeneration of these tissues. a total of 58 subjects (30 male and 28 female) was enrolled and classified in osteoporotic (OP, n = 8), osteopenic (Ope, n = 30) and healthy (CTR, n = 20) subjects, according to BMD measures. femoral head bone samples and vastus lateralis muscle samples were collected during hip arthroplasty surgeries. Inductively coupled plasma mass spectrometry (ICP-MS) analysis showed increased levels of Al, Cd and Pb in OP and ope bone tissue compared to CTR subjects (p = 0.04, p = 0.005 and p = 0.01, respectively). whereas, increased levels of Co, Cd and Pb were measured in OP and ope muscle tissues, compared to CTRs (p < 0.001, p = 0.02 and p = 0.01, respectively). In addition, Al, Cd and Pb levels in bone and Cd and Co levels in muscle were negatively correlated with BMD. a negative association among Co, Cd, Cr and Hg levels and muscle fibers diameter was also observed in muscle tissues. this study assessed that metal exposure can affects bone and muscle tissue quality and may contribute to the onset and progression of musculoskeletal diseases such as osteoporosis. therefore, it is important to implement metal exposure assessment and their impact on disease development, in order to manage and prevent metal accumulation effects on bone and muscle quality.